type 2 diabetes
Age, gender, type 2 diabetes, renal impairment, smoking and race do       not appear to influence the pharmacokinetics of troglitazone and its 2 major       metabolites.
Age, gender,  @SUBJECT$ , renal impairment, smoking and race do       not appear to  @PREDICAT$  the  @OBJECT$  of troglitazone and its 2 major       metabolites.